AXSOME THERAPEUTICS, INC. Income Tax Expense
AXSOME THERAPEUTICS, INC. (AXSM) reported Income Tax Expense of $128.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-10
- AXSOME THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2026-06-30 was $128.00K.
- AXSOME THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2026-03-31 was $0.00.
- AXSOME THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2025-12-31 was $430.00K, a 405.88% increase year-over-year.
- AXSOME THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00.
- AXSOME THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2025 was -$530.00K, a 723.53% decline from fiscal 2024.
- AXSOME THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2024 was $85.00K, a 91.15% decline from fiscal 2023.
- AXSOME THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2023 was $960.00K.
- AXSOME THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2022 was $0.00.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $128.00K 10-Q · filed 2026-08-10 | $128.00K 10-Q · filed 2026-08-10 | $558.00K derived: sum of 3 quarters · filed 2026-08-10 | $558.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-04 | $430.00K derived: sum of 2 quarters · filed 2026-05-04 | $430.00K derived: sum of 3 quarters · filed 2026-05-04 | -$530.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $430.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $430.00K derived: sum of 2 quarters · filed 2026-02-23 | -$530.00K derived: sum of 3 quarters · filed 2026-08-10 | -$530.00K 10-K · filed 2026-02-23 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-03 | -$960.00K derived: sum of 2 quarters · filed 2026-08-10 | -$960.00K 10-Q · filed 2025-11-03 | -$875.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$960.00K 10-Q · filed 2026-08-10 | -$960.00K 10-Q · filed 2026-08-10 | -$875.00K derived: sum of 3 quarters · filed 2026-08-10 | -$875.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-04 | $85.00K derived: sum of 2 quarters · filed 2026-05-04 | $85.00K derived: sum of 3 quarters · filed 2026-05-04 | $85.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $85.00K derived: sum of 2 quarters · filed 2026-02-23 | $85.00K derived: sum of 3 quarters · filed 2026-02-23 | $85.00K 10-K · filed 2026-02-23 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-03 | $0.00 derived: sum of 2 quarters · filed 2025-11-03 | $0.00 10-Q · filed 2025-11-03 | -$325.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-04 | $0.00 10-Q · filed 2025-08-04 | -$325.00K derived: sum of 3 quarters · filed 2026-02-23 | -$1.00M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-05 | -$325.00K derived: sum of 2 quarters · filed 2026-02-23 | -$1.00M derived: sum of 3 quarters · filed 2026-02-23 | -$1.62M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | -$325.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$1.00M derived: sum of 2 quarters · filed 2026-02-23 | -$1.62M derived: sum of 3 quarters · filed 2026-02-23 | $960.00K 10-K · filed 2026-02-23 |
| 2023-09-30 | -$678.00K 10-Q · filed 2024-11-12 | -$1.29M derived: sum of 2 quarters · filed 2024-11-12 | $1.28M 10-Q · filed 2024-11-12 | $1.28M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$617.00K 10-Q · filed 2024-08-05 | $1.96M 10-Q · filed 2024-08-05 | $1.96M derived: sum of 3 quarters · filed 2024-08-05 | $1.96M derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $2.58M 10-Q · filed 2024-05-06 | $2.58M derived: sum of 2 quarters · filed 2024-05-06 | $2.58M derived: sum of 3 quarters · filed 2024-05-06 | $2.58M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $0.00 derived: sum of 2 quarters · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 | $0.00 derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | $0.00 derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-02 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | $0.00 derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $0.00 derived: sum of 2 quarters · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 | $0.00 derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | $0.00 derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-02 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | $0.00 derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $0.00 derived: sum of 2 quarters · filed 2021-11-08 | $0.00 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 | |||
| 2018-12-31 | $217.42K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 10-K · filed 2021-03-01 | |
| 2018-09-30 | -$217.42K 10-Q · filed 2018-11-09 | -$217.42K 10-Q · filed 2018-11-09 | ||
| 2017-12-31 | $207.11K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 derived: sum of 2 quarters · filed 2020-03-12 | $0.00 10-K · filed 2020-03-12 | |
| 2017-09-30 | -$207.11K 10-Q · filed 2018-11-09 | -$207.11K 10-Q · filed 2018-11-09 | ||
| 2016-12-31 | $0.00 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |